1. Staging systems of hepatocellular carcinoma: A review
   Sreeshma Tellapuri et al, 2018, Indian Journal of Gastroenterology CrossRef
2. Scoring systems for the management of oncological hepato-pancreato-biliary patients
   Alexander W. Coombs et al, 2022, Annals of Hepato-Biliary-Pancreatic Surgery CrossRef
3. Overview of Clinical HCC and Its Management
   Brian I. Carr, 2021, Liver Cancer in the Middle East CrossRef
4. Prognostic Value of Macrophage-Associated Long Non-Coding RNA Expression for Hepatocellular Carcinoma
   Guan-Yu Chen et al, 2022, Cancer Management and Research CrossRef
5. Another treatment option for locally advanced hepatocellular carcinoma: Interventional arterial infusion of FOLFOX chemotherapy from the FOHAIC-1 study
   Ning Lyu et al, 2022, Visualized Cancer Medicine CrossRef
6. A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy
   Yang‐Xun Pan et al, 2019, Cancer Communications CrossRef
7. Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations
   Ming Zhao et al, 2024, Hepatology International CrossRef
8. Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy
   Cheng Ma et al, 2023, Journal of Hepatocellular Carcinoma CrossRef
9. Prognostic evaluation of HCC patients undergoing surgical resection: an analysis of 8 different staging systems
   Jan Bednarsch et al, 2021, Langenbeck's Archives of Surgery CrossRef
10. Prognosis of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization(MC-hccAI 001): Development and Validation of the ALFP Score
    Baocuo Gong et al, 2023, Journal of Hepatocellular Carcinoma CrossRef
11. The Pretreatment Neutrophil-to-Lymphocyte Ratio as a Near-Term Prognostic Indicator in Patients with Locally Advanced Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy: A Propensity Score Matching Cohort Study
    Weifu Liu et al, 2024, British Journal of Hospital Medicine CrossRef
12. An immune-related biomarker index for predicting the effectiveness of immunotherapy and prognosis in hepatocellular carcinoma
    Xiang’an Wu et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
13. G Protein-Coupled Receptor Kinase 4 Is a Novel Prognostic Factor in Hepatocellular Carcinoma
    Yunxiu Luo et al, 2022, Disease Markers CrossRef
14. Enhanced antitumour effect for hepatocellular carcinoma in the advanced stage using a cyclodextrin-sorafenib-chaperoned inclusion complex
    Chiuyen Phan et al, 2019, Biomaterials Science CrossRef
15. Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer
    Po-Shuan Huang et al, 2023, Cells CrossRef
16. Machine learning-based development and validation of a scoring system for progression-free survival in liver cancer
    Xiaoli Liu et al, 2020, Hepatology International CrossRef
17. Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.
    Giovanni Marasco et al, 2021, Digestive and Liver Disease CrossRef
18. Dynamically prognosticating patients with hepatocellular carcinoma through survival paths mapping based on time-series data
    Lujun Shen et al, 2018, Nature Communications CrossRef
19. Long-term results of surgical treatment of hepatocellular cancer in Russian real practice
    V. V. Petkau et al, 2024, Meditsinskiy sovet = Medical Council CrossRef
20. Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications
    Alessandro Vitale et al, 2021, Cancers CrossRef